Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Research Review

Showing 1–3 of 3 articles · Keyword: Regenerative medicine Clear keyword

Discover nano2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Exosomes in regenerative medicine from biological messengers to engineered nanocarriers for precision therapeutics

Ghosh S, Bhaskar R, Singh Kk, Sharma S, Han Ss, Sinha Jk

Exosomes have emerged as a promising class of next-generation nanocarriers at the intersection of regenerative medicine and drug delivery. Compared with conventional synthetic nanocarriers and stem cell-based therapies, exosomes offer unique advantages, including intrinsic biocompatibility, low immunogenicity…

Read the article

Drug metabolism and bioanalysis2026ReviewNon-viral Gene DeliveryDrug Delivery

2. Biomaterial-Based Drug Delivery Systems: Bridging Advances and Applications in Regenerative Medicine

Ansari I, Yadav S, Prajapati S

In regenerative medicine, biomaterial-based medication delivery systems are a gamechanger because they allow for the restoration of function and the healing of damaged tissues. This study aims to examine the potential of synthetic and natural biomaterials for the delivery of medications and the regeneration of…

Read the article

Nanotechnology2026ResearchDrug Delivery

3. Integrating Nanomaterials with Extracellular Vesicles: Engineering Strategies and Translational Perspectives

Le Th, Phan Lmt

Extracellular vesicles (EVs), particularly stem cell-derived exosomes, serve as vital natural nanocarriers in regenerative medicine, immune modulation, and targeted drug delivery due to their innate ability to transport bioactive cargo across complex biological barriers. Despite this potential, the therapeutic…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.